CHEBI:18332 - L-thyroxine

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name L-thyroxine
ChEBI ID CHEBI:18332
ChEBI ASCII Name L-thyroxine
Definition The L-enantiomer of thyroxine.
Stars This entity has been manually annotated by the ChEBI Team.
Secondary ChEBI IDs CHEBI:7663, CHEBI:45848, CHEBI:13177, CHEBI:21406
Supplier Information ChemicalBook:CB7852954, eMolecules:478134, ZINC000000895323
Download Molfile XML SDF
more structures >>
Wikipedia License
Phenylacetaldehyde is an organic compound used in the synthesis of fragrances and polymers. Phenylacetaldehyde is an aldehyde that consists of acetaldehyde bearing a phenyl substituent; the parent member of the phenylacetaldehyde class of compounds. It has a role as a human metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite and a mouse metabolite. It is an alpha-CH2-containing aldehyde and a member of phenylacetaldehydes. Phenylacetaldehyde is one important oxidation-related aldehyde. Exposure to styrene gives phenylacetaldehyde as a secondary metabolite. Styrene has been implicated as reproductive toxicant, neurotoxicant, or carcinogen in vivo or in vitro. Phenylacetaldehyde could be formed by diverse thermal reactions during the cooking process together with C8 compounds is identified as a major aroma–active compound in cooked pine mushroom. Phenylacetaldehyde is readily oxidized to phenylacetic acid. Therefore will eventually be hydrolyzed and oxidized to yield phenylacetic acid that will be excreted primarily in the urine in conjugated form.
Read full article at Wikipedia
Formula C15H11I4NO4
Net Charge 0
Average Mass 776.87006
Monoisotopic Mass 776.68669
InChI InChI=1S/C15H11I4NO4/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23/h1-2,4-5,12,21H,3,20H2,(H,22,23)/t12-/m0/s1
InChIKey XUIIKFGFIJCVMT-LBPRGKRZSA-N
SMILES N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(O)=O
Metabolite of Species Details
Mus musculus (NCBI:txid10090) Source: BioModels - MODEL1507180067 See: PubMed
Homo sapiens (NCBI:txid9606) See: DOI
Roles Classification
Chemical Role(s): Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
Biological Role(s): antithyroid drug
A drug used to treat hyperthyroidism by reducing the excessive production of thyroid hormones.
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
thyroid hormone
Any hormone produced by the thyroid gland
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
mitogen
A chemical substance that encourages a cell to commence cell division, triggering mitosis.
(via thyroxine )
Application(s): antithyroid drug
A drug used to treat hyperthyroidism by reducing the excessive production of thyroid hormones.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing L-thyroxine (CHEBI:18332) has role antithyroid drug (CHEBI:50671)
L-thyroxine (CHEBI:18332) has role human metabolite (CHEBI:77746)
L-thyroxine (CHEBI:18332) has role mouse metabolite (CHEBI:75771)
L-thyroxine (CHEBI:18332) has role thyroid hormone (CHEBI:60311)
L-thyroxine (CHEBI:18332) is a 2-halophenol (CHEBI:53291)
L-thyroxine (CHEBI:18332) is a L-phenylalanine derivative (CHEBI:84144)
L-thyroxine (CHEBI:18332) is a iodophenol (CHEBI:24863)
L-thyroxine (CHEBI:18332) is a non-proteinogenic L-α-amino acid (CHEBI:83822)
L-thyroxine (CHEBI:18332) is a thyroxine (CHEBI:30660)
L-thyroxine (CHEBI:18332) is conjugate acid of L-thyroxine(1−) (CHEBI:60302)
L-thyroxine (CHEBI:18332) is enantiomer of D-thyroxine (CHEBI:30659)
L-thyroxine (CHEBI:18332) is tautomer of L-thyroxine zwitterion (CHEBI:58448)
Incoming desiccated thyroid extract (CHEBI:9584) has part L-thyroxine (CHEBI:18332)
L-thyroxine(1−) (CHEBI:60302) is conjugate base of L-thyroxine (CHEBI:18332)
D-thyroxine (CHEBI:30659) is enantiomer of L-thyroxine (CHEBI:18332)
L-thyroxine residue (CHEBI:90872) is substituent group from L-thyroxine (CHEBI:18332)
L-thyroxine zwitterion (CHEBI:58448) is tautomer of L-thyroxine (CHEBI:18332)
IUPAC Name
L-thyroxine
Synonyms Sources
3,3',5,5'-tetraiodo-L-thyronine ChemIDplus
3,5,3',5'-TETRAIODO-L-THYRONINE PDBeChem
3,5,3',5'-tetraiodo-L-thyronine ChemIDplus
4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodo-L-phenylalanine IUPAC
L-T4 ChemIDplus
L-Thyroxine KEGG COMPOUND
Levothyroxin KEGG COMPOUND
levothyroxine ChemIDplus
LT4 ChEBI
O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine PDBeChem
T4 KEGG COMPOUND
T4 ChEBI
Manual Xrefs Databases
2646 DrugCentral
3004 VSDB
C01829 KEGG COMPOUND
D08125 KEGG DRUG
DB00451 DrugBank
Levothyroxine Wikipedia
LSM-5447 LINCS
T44 PDBeChem
View more database links
Registry Numbers Types Sources
2228515 Beilstein Registry Number Beilstein
51-48-9 CAS Registry Number KEGG COMPOUND
51-48-9 CAS Registry Number ChemIDplus
7002831 Beilstein Registry Number Beilstein
Citations
Alzoubi KH, Alkadhi KA (2014)
Levothyroxin replacement therapy restores hypothyroidism induced impairment of L-LTP induction: critical role of CREB.
Brain research bulletin 100, 29-37 [PubMed:24216002]
[show Abstract]
Ianiro G, Mangiola F, Di Rienzo TA, Bibbò S, Franceschi F, Greco AV, Gasbarrini A (2014)
Levothyroxine absorption in health and disease, and new therapeutic perspectives.
European review for medical and pharmacological sciences 18, 451-456 [PubMed:24610609]
[show Abstract]
Anagnostis P, Efstathiadou ZA, Slavakis A, Selalmatzidou D, Poulasouchidou M, Katergari S, Karathanasi E, Dogramatzi F, Kita M (2014)
The effect of L-thyroxine substitution on lipid profile, glucose homeostasis, inflammation and coagulation in patients with subclinical hypothyroidism.
International journal of clinical practice 68, 857-863 [PubMed:24548294]
[show Abstract]
Prasad BB, Madhuri R, Tiwari MP, Sharma PS (2010)
Layer-by-layer assembled molecularly imprinted polymer modified silver electrode for enantioselective detection of D- and L-thyroxine.
Analytica chimica acta 681, 16-26 [PubMed:21035598]
[show Abstract]
Prasad BB, Tiwari MP, Madhuri R, Sharma PS (2010)
Enatioselective quantitative separation of D- and L-thyroxine by molecularly imprinted micro-solid phase extraction silver fiber coupled with complementary molecularly imprinted polymer-sensor.
Journal of chromatography. A 1217, 4255-4266 [PubMed:20483419]
[show Abstract]
Pabla D, Akhlaghi F, Zia H (2009)
A comparative pH-dissolution profile study of selected commercial levothyroxine products using inductively coupled plasma mass spectrometry.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 72, 105-110 [PubMed:18996189]
[show Abstract]
Shionoya H, Sugihara Y, Okano K, Sagami F, Mikami T, Katayama K (2004)
Studies on experimental iodine allergy: 1. Antigen recognition of guinea pig anti-iodine antibody.
The Journal of toxicological sciences 29, 131-136 [PubMed:15206581]
[show Abstract]
Sandhu GS, Steele R, Gonnella NC (1991)
Effect of L-thyroxine (LT4) and D-thyroxine (DT4) on cardiac function and high-energy phosphate metabolism: a 31P NMR study.
Magnetic resonance in medicine 18, 237-243 [PubMed:2062236]
[show Abstract]
Last Modified
18 February 2021